BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Atas, E. [1 ]
Kesik, V. [1 ]
Babacan, O. [1 ]
Korkmazer, N. [2 ]
机构：
[1] Gulhane Mil Med Acad, Dept Pediat Oncol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Pediat, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P219
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [1] Long-Term Results for Children with High-Risk Neuroblastoma Treated on the Randomized High-Dose Therapy Trial of Busulphan-Melphalan Versus Carboplatin-Etoposide-Melphalan: A Siopen Study
    Ladenstein, R.
    Poetschger, U.
    Brock, P.
    Luksch, R.
    Castel, V.
    Yaniv, I.
    Papadakis, V.
    Laureys, G.
    Malis, J.
    Balwierz, W.
    Kogner, P.
    Ambros, P.
    Holmes, K.
    Gaze, M.
    Schreier, G.
    Garaventa, A.
    Vassal, G.
    Michon, J.
    Pearson, A.
    Valteau-Couanet, D.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S32 - S32
  • [2] Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma
    Ria, R
    Falzetti, F
    Ballanti, S
    Minelli, O
    Di Lanni, M
    Cimminiello, M
    Vacca, A
    Dammacco, F
    Martelli, MF
    Tabilio, A
    HEMATOLOGY JOURNAL, 2004, 5 (02) : 118 - 122
  • [3] Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation
    Eltelbanei, Mohamed A.
    El-Bassiouny, Noha A.
    Abdalla, Mahmoud Salah
    Khalaf, Mohamed
    Werida, Rehab H.
    BMC CANCER, 2024, 24 (01)
  • [4] INTRAVENOUS BUSULPHAN IN COMBINATION WITH ETOPOSIDE AND MELPHALAN USED AS CONDITIONING REGIMEN FOR AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN LYMPHOMAS: EVALUATION OF TOXICITY
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Papalexandri, A.
    Penopoulos, V.
    Sakellari, I.
    Anagnostopoulos, A.
    Fassas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 449 - 450
  • [5] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [6] Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy
    Mallouri, Despina
    Sakellari, Ioanna
    Batsis, Ioannis
    Konstantinou, Varnavas
    Baliakas, Panayotis
    Antoniou, Athanasios
    Apostolou, Chrisa
    Anagnostopoulos, Achilles
    Fassas, Athanasios
    BLOOD, 2010, 116 (21) : 567 - 567
  • [7] Busulfan and melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 262 - 263
  • [8] TEAM (thiotepa, etoposide, cytarabine, melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M.
    Merla, E.
    Dell'Olio, M.
    Scalzulli, P.
    Capalbo, S.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S214 - S214
  • [9] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M. M.
    Merla, E.
    Dell'Olio, M.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Musto, P.
    Rana, A.
    Guarini, A.
    Di Tonno, P.
    Pastore, D.
    D'Elia, M.
    Specchia, G.
    Capalbo, S.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S248 - S248
  • [10] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Ferrara, F.
    Greco, M.
    Dell'Olio, M.
    Scalzulli, P.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Capalbo, S.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 66 - 66
12345